CMS In Brief
This article was originally published in The Gray Sheet
Executive Summary
Transcatheter valve coding proposed
You may also be interested in...
CMS In Brief
2012 new-tech add-on payments
DME Competitive Bidding: 32% Cost-Cutting Expected From Revived Program
CMS plans to cut reimbursement an average 32% next year for certain durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) sold in nine markets, the agency announced July 1
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.